Russell Investments Group Ltd. Raises Stock Holdings in Biomerica, Inc. (NASDAQ:BMRA)

Russell Investments Group Ltd. increased its position in Biomerica, Inc. (NASDAQ:BMRAFree Report) by 173.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 174,273 shares of the company’s stock after acquiring an additional 110,505 shares during the period. Russell Investments Group Ltd. owned approximately 1.04% of Biomerica worth $326,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in BMRA. Point72 Asset Management L.P. purchased a new stake in Biomerica in the fourth quarter valued at $1,407,000. Jane Street Group LLC acquired a new position in shares of Biomerica during the 1st quarter worth approximately $57,000. Finally, Geode Capital Management LLC boosted its holdings in shares of Biomerica by 16.4% during the 4th quarter. Geode Capital Management LLC now owns 90,817 shares of the company’s stock worth $304,000 after purchasing an additional 12,811 shares during the last quarter. Hedge funds and other institutional investors own 26.25% of the company’s stock.

Biomerica Trading Up 0.8 %

Biomerica stock opened at $1.29 on Tuesday. The company has a 50-day moving average price of $1.31 and a 200 day moving average price of $1.62. Biomerica, Inc. has a 12-month low of $1.03 and a 12-month high of $5.25. The stock has a market cap of $21.70 million, a P/E ratio of -2.58 and a beta of -0.62.

Biomerica Company Profile

(Free Report)

Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.

Featured Stories

Institutional Ownership by Quarter for Biomerica (NASDAQ:BMRA)

Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with's FREE daily email newsletter.